62 completed, 5 unknown, 2 terminated, 1 not yet recruiting. 39 Phase 3, 14 Phase 4, 6 Phase 2, 5 Phase 1, 4 Not applicable.
Follow Perennial Allergic Rhinitis: new trials by email Literature Review of Perennial Allergic Rhinitis trials Research Report on Perennial Allergic Rhinitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis JYB1904, Placebo+JYB1904 - Perennial Allergic Rhinitis | Phase 2 | Not yet recruiting | Jemincare | 135 | 2026-04-01 | 2026-03-09 |
| Bioequivalence Study of AJU-R713 and R713R in Healthy Adult Volunteers AJU-R713, R713R - Bronchial Asthma, Perennial Allergic Rhinitis | Phase 1 | Completed | AJU Pharm Co., Ltd. | 62 | 2025-12-12 | 2026-09-18 |
| Investigation of the Effects of a Multispecies Probiotic Formulation on Perennial Allergic Rhinitis Multi-species probiotic powder for oral solution. Dietary supplement containing six bacterial strains (Lactobacillus and Bifidobacterium species), Placebo Powder for Oral Solution - Perennial Allergic Rhinitis | Not applicable | Completed | Winclove B.V. | 97 | 2025-09-01 | 2026-09-09 |
| Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray Azelastine Hydrochloride/ Fluticasone propionate nasal spray, 'DYMISTA' NASAL SPRAY - Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis | Phase 1 | Completed | Humanis Saglık Anonim Sirketi | 56 | 2023-03-24 | 2023-12-28 |
| Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis MM09 allergoid-mannan conjugates subcutaneous (3.000 UTm/mL), MM09 allergoid-mannan conjugates Sublingual (3.000 UTm/mL), MM09 allergoid-mannan conjugates Sublingual (9.000 UTm/mL) - House Dust Mite Allergy, Perennial Allergic Rhinitis | Phase 3 | Unknown | Inmunotek S.L. | 400 | 2022-12-01 | 2022-11-18 |
| As Needed Versus Regular Intranasal Corticosteroid in Children With Perennial Allergic Rhinitis Intranasal Drug (INCS = Fluticasone furoate nasal spray, Placebo = Normal saline nasal spray) - Perennial Allergic Rhinitis, Child, Only | Phase 3 | Completed | Mahidol University | 68 | 2022-04-04 | 2025-11-18 |
| Efficacy, Safety and Underlying Mechanisms of Sphenopalatine Ganglion Acupuncture for Perennial Allergic Rhinitis SPA acupuncture, sham acupuncture - Perennial Allergic Rhinitis | Not applicable | Unknown | Beijing Tongren Hospital | 40 | 2021-12-01 | 2021-07-26 |
| Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers Treatment A, Treatment B, Treatment C - Perennial Allergic Rhinitis, Rhinitis, Allergic | Not applicable | Completed | Altamira Medica Ltd. | 37 | 2021-11-10 | 2024-09-19 |
| Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis MM09-MG01(30.000-30.000), MG01(30.000), MM09(30.000) - Allergic Rhinoconjunctivitis, Perennial Allergic Rhinitis | Phase 3 | Terminated | Inmunotek S.L. | 18 | 2021-04-30 | 2023-12-19 |
| The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy AIT, NAPT - Perennial Allergic Rhinitis, Seasonal Allergic Rhinitis | Recruiting | Universitaire Ziekenhuizen KU Leuven | 200 | 2020-07-16 | 2026-05-01 | |
| Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis HCP1102, HGP1408 - Perennial Allergic Rhinitis | Phase 3 | Completed | Hanmi Pharmaceutical Company Limited | 174 | 2018-10-23 | 2020-03-27 |
| Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap. Perennial Allergic Rhinitis, Asthma | Completed | Hanmi Pharmaceutical Company Limited | 2671 | 2017-11-17 | 2021-11-26 | |
| Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT Therapy With Acarovac® Hausstaubmilbe Acarovac - Perennial Allergic Rhinitis | Completed | University Hospital of Cologne | 32 | 2017-03-01 | 2019-04-24 | |
| To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients HL151, placebo - Perennial Allergic Rhinitis | Phase 3 | Completed | Hanlim Pharm. Co., Ltd. | 272 | 2017-02-07 | 2018-08-31 |
| Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis SCRT, Placebos - Perennial Allergic Rhinitis | Phase 3 | Unknown | Kyung Hee University Hospital at Gangdong | 154 | 2016-12-31 | 2017-03-14 |
| Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR) GSP 301 NS, GSP 301 Placebo NS pH 3.7, GSP 301 Placebo NS pH 7.0 - Perennial Allergic Rhinitis | Phase 3 | Completed | Glenmark Specialty S.A. | 601 | 2016-04-01 | 2020-02-26 |
| Subcutaneous Immunotherapy for Mouse in Adults Mouse Allergenic Extract - Asthma, Perennial Allergic Rhinitis | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 12 | 2015-10-01 | 2018-03-07 |
| Topical Nasal Fluticasone Propionate in the Control of Allergic Rhinitis SymptomsPerene Fluticasone Propionate - Perennial Allergic Rhinitis | Phase 3 | Completed | Libbs Farmacêutica LTDA | 566 | 2014-07-04 | 2020-04-08 |
| Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean AGR tablet, Placebo (for AGR tablet and/or Active Comparator), Active Comparator - Allergic Rhinitis, Perennial Allergic Rhinitis | Phase 3 | Completed | Ahn-Gook Pharmaceuticals Co.,Ltd | 324 | 2013-12-01 | 2018-03-13 |
| A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200) Desloratadine 5 mg, Placebo - Perennial Allergic Rhinitis | Phase 3 | Completed | Organon and Co | 608 | 2013-08-20 | 2024-06-18 |
Showing 20 of 71. Sign in to see all of them.
Rhinitis, Allergic, Perennial (71) · Rhinitis, Allergic, Seasonal (14) · Rhinitis, Allergic (13) · Hypersensitivity (8) · Asthma (5) · Rhinitis (5) · Dust Mite Allergy (3) · Rhinorrhea (2) · Fatigue (1) · Immune System Diseases (1) · Nasal Obstruction (1) · Nose Diseases (1) · Respiratory Tract Diseases (1) · Sleep Apnea, Obstructive (1) · Sleep Wake Disorders (1)
Hypersensitivity, Immediate (71) · Otorhinolaryngologic Diseases (71) · Respiratory Hypersensitivity (71) · Immune System Diseases (70) · Nose Diseases (70) · Respiratory Tract Diseases (70) · Rhinitis (66) · Hypersensitivity (63) · Rhinitis, Allergic (58) · Bronchial Diseases (5) · Infections (5) · Lung Diseases (5) · Lung Diseases, Obstructive (5) · Respiratory Tract Infections (5) · Pathological Conditions, Signs and Symptoms (4)
Mometasone Furoate (8) · ciclesonide (7) · Cetirizine (4) · azelastine (4) · desloratadine (4) · levocetirizine (4) · Nasal Sprays (3) · montelukast (3) · Budesonide (2) · Fluticasone (2) · Loratadine (2) · Olopatadine Hydrochloride (2) · bepotastine besilate (2) · Beclomethasone (1) · Calcium Dobesilate (1)
Organon and Co (9) · Sumitomo Pharma America, Inc. (8) · AstraZeneca (5) · Hanmi Pharmaceutical Company Limited (3) · Meda Pharmaceuticals (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Tanabe Pharma Corporation (3) · Alcon Research (2) · Hanlim Pharm. Co., Ltd. (2) · Inmunotek S.L. (2) · Merck Sharp & Dohme LLC (2) · AAADRS Clinical Research Center (1) · AJU Pharm Co., Ltd. (1) · ALK-Abelló A/S (1) · Ahn-Gook Pharmaceuticals Co.,Ltd (1)
United States (27) · South Korea (9) · Japan (3) · Canada (2) · Spain (2) · Austria (1) · Belgium (1) · Brazil (1) · China (1) · France (1) · Germany (1) · Hong Kong (1) · India (1) · Taiwan (1) · Thailand (1)
Luo Zhang (2) · Robert Wood, MD (2) · Amy Schaberg, B.S.N. (1) · Ana Isabel Tabar Purroy, MD. PhD (1) · Ana Isabel Tabar Purroy, MD; PhD (1) · Bertil Andersson (1) · Bok Yang Pyun, MD (1) · Byoung-Whui Choi (1) · Chae-Seo Rhee, M.D. (1) · Chang-Hoon Kim, M.D. (1)
PMID 24184147, PMID 26364765, PMID 17619558, PMID 17651373, PMID 18430310, PMID 20642206, PMID 22077106, PMID 22092947, PMID 22370530, PMID 23062389, PMID 24169063, PMID 24574125, PMID 24814759, PMID 27785374, PMID 28963290, PMID 30027002, PMID 30525743, PMID 31248471, PMID 37920410, PMID 39885937, PMID 42617693
2018 (1)